サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439238

神経モニタリングシステム - 世界市場の考察、競合情勢、市場予測（2030年）

Nerve Monitoring System - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
神経モニタリングシステム - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の神経モニタリングシステムの市場規模は、2023年に12億8,000万米ドル、2030年までに16億3,000万米ドルに達し、2024年～2030年の予測期間にCAGRで4.17％の成長が見込まれます。神経モニタリングシステムの需要は主に、神経関連障害患者数の増加、これらの処置に対する医療費償還の容易な利用可能性、先進の製品に対する需要の増加、市場におけるデバイスメーカーの強力なプレゼンスなどによって促進されています。

神経モニタリングシステムの市場力学

神経モニタリングシステム市場の成長に影響を与える主な要因の1つは、世界中での手術件数の負担の増大です。

OECDによると、英国では2020年に約9,451件の冠動脈バイパス移植術が実施されました。また、ドイツでは同年、約3万8,859件の冠動脈バイパス移植術が行われました。同じ資料によると、スイスでは2020年に2万6,355件の経管冠動脈形成術が行われました。同年、スペインでは5万3,993件の経管冠動脈形成術が行われました。

血管造影や血管内インターベンションに伴う神経損傷はまれで、通常は一過性ですが、重大な機能障害をもたらす可能性があり、大部分は回避可能です。肋間神経損傷は、冠動脈バイパス術-内胸動脈手術を受ける全患者の4分の3で発生する可能性があります。

また、オーストラリアでは、2019年に約4万7,083件の扁桃摘出術が行われました。舌咽神経は扁桃床に位置するため、扁桃摘出術の際に特に損傷しやすいです。

手術中に神経モニタリングシステムを使用すれば、どのような外科手術でも神経が損傷するリスクを減らすことができます。

このように、さまざまな外科手術の増加は神経損傷のリスクを増大させ、神経モニタリングシステムの需要の増加につながり、その結果、神経モニタリングシステム市場全体を今後数年間押し上げることになります。

しかし、頻繁な製品リコールやデバイスの高いコストが神経モニタリングシステム市場の成長抑制要因になる可能性があります。

神経モニタリングシステム市場のセグメント分析

神経モニタリングシステム市場の技術セグメントでは、筋電図（EMG）カテゴリが最大のシェアを占めると予測されています。

EMGは、骨格筋とそれに関連する運動神経細胞の電気的活動の分析、評価、記録に使用されます。筋障害、神経障害、筋と神経の接続に影響を及ぼす障害の正確で効果的な診断に役立ちます。

また、EMGは腰椎除圧術や腰椎間固定術の際に、どのようなアプローチからでも神経をモニターすることができます。前方（ALIF）、後方（PLIF/TLIF）、側方（XLIF®）、腰椎椎間板全置換術、馬尾手術、前頚椎椎間板切除・固定術（ACDF）、頚椎椎間板全置換術、後頚椎固定術（PCF）、脊髄腫瘍切除術、側弯症手術、胸椎椎体形成術などです。

さらに、製品の発売や承認の増加も、予測期間に筋電図の需要を増加させる見込みです。例えば2022年11月、Xavant Technologyは、定量的NMTモニターSTIMPODシリーズのセンサー技術を筋電図（EMG）を含むように拡張することをFDAが承認したと発表しました。これまでXavantの定量的神経筋モニタリング（NMT）モニターは加速筋電図（AMG）センサーのみを搭載していました。

先進国におけるEMGを用いた外科手術に対する政府による有利な償還政策と、術中用途におけるEMG神経モニタリングの大幅な利用が、神経モニタリングシステム市場を押し上げる見込みです。

北米が神経モニタリングシステム市場全体を独占する見込み

予測期間に北米が神経モニタリングシステム市場全体を独占すると予測されます。この独占は、神経モニタリングシステムの先進技術に対する需要の高まり、外科手術数の増加、同地域の主要市場企業のプレゼンスによるものです。

当レポートでは、世界の神経モニタリングシステム市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 神経モニタリングシステム市場レポートのイントロダクション

第2章 神経モニタリングシステム市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 神経モニタリングシステム市場の主な要因の分析

  • 神経モニタリングシステム市場の促進要因
    • 神経関連疾患の患者数の増加
    • これらの処置に対する医療費償還の容易な利用可能性
    • 先進の製品に対する需要の増加
  • 神経モニタリングシステム市場の抑制要因と課題
    • 頻繁な製品リコール
    • デバイスの高いコスト
  • 神経モニタリングシステム市場の機会
    • ウェアラブルデバイスの選好
    • マルチモーダルモニタリングの利用可能性

第5章 神経モニタリングシステムのポーターのファイブフォース分析

第6章 神経モニタリングシステム市場レイアウト

  • 製品別
    • 神経モニター
    • 神経刺激電極、プローブ
  • 技術別
    • 筋電図検査（EMG）
    • 脳波検査（EEG）
    • 皮質電図検査（ECOG）
    • 誘発電位（EP）
  • 用途別
    • 脳神経外科
    • 耳鼻咽喉科手術
    • 心血管
    • その他
  • エンドユーザー別
    • 病院
    • 外来手術センター
  • 地域別
    • 北米の神経モニタリングシステム市場（2021年～2030年）
    • 欧州の神経モニタリングシステム市場（2021年～2030年）
    • アジア太平洋の神経モニタリングシステム市場（2021年～2030年）
    • その他の地域の神経モニタリングシステム市場（2021年～2030年）

第7章 神経モニタリングシステムの企業と製品のプロファイル

  • NuVasive®, Inc.
  • Nihon Kohden Corporation
  • Natus Medical Incorporated
  • Innopsys Inc.
  • Neurovision Medical Products
  • NeuroWave Systems Inc.
  • Cadwell Industries, Inc.
  • Dr. Langer Medical GmbH
  • Inomed Medizintechnik GmbH
  • Medtronic PLC.
  • Symmetry Surgical
  • Checkpoint Surgical Inc.
  • Neurosign®
  • EMS Handels Gesellschaft mbH
  • Halyard Health

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Nerve Monitoring System Market in Global (2021-2030)
  • Table 3: Nerve Monitoring System Market in Global by Product (2021-2030)
  • Table 4: Nerve Monitoring System Market in Global by Technology (2021-2030)
  • Table 5: Nerve Monitoring System Market in Global by Application (2021-2030)
  • Table 6: Nerve Monitoring System Market in Global by End-User (2021-2030)
  • Table 7: Nerve Monitoring System Market in Global by Geography (2021-2030)
  • Table 8: Nerve Monitoring System Market in North America (2021-2030)
  • Table 9: Nerve Monitoring System Market in the US (2021-2030)
  • Table 10: Nerve Monitoring System Market in Canada (2021-2030)
  • Table 11: Nerve Monitoring System Market in Mexico (2021-2030)
  • Table 12: Nerve Monitoring System Market in Europe (2021-2030)
  • Table 13: Nerve Monitoring System Market in France (2021-2030)
  • Table 14: Nerve Monitoring System Market in Germany (2021-2030)
  • Table 15: Nerve Monitoring System Market in the United Kingdom (2021-2030)
  • Table 16: Nerve Monitoring System Market in Italy (2021-2030)
  • Table 17: Nerve Monitoring System Market in Spain (2021-2030)
  • Table 18: Nerve Monitoring System Market in Rest of Europe (2021-2030)
  • Table 19: Nerve Monitoring System Market in Asia-Pacific (2021-2030)
  • Table 20: Nerve Monitoring System Market in China (2021-2030)
  • Table 21: Nerve Monitoring System Market in Japan (2021-2030)
  • Table 22: Nerve Monitoring System Market in India (2021-2030)
  • Table 23: Nerve Monitoring System Market in Australia (2021-2030)
  • Table 24: Nerve Monitoring System Market in South Korea (2021-2030)
  • Table 25: Nerve Monitoring System Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Nerve Monitoring System Market in the Rest of the World (2021-2030)
  • Table 27: Nerve Monitoring System Market in the Middle East (2021-2030)
  • Table 28: Nerve Monitoring System Market in Africa (2021-2030)
  • Table 29: Nerve Monitoring System Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Nerve Monitoring SystemMarket in Global (2021-2030)
  • Figure 3: Nerve Monitoring System Market in Global by Product (2021-2030)
  • Figure 4: Nerve Monitoring System Market in Global by Technology (2021-2030)
  • Figure 5: Nerve Monitoring System Market in Global by Application (2021-2030)
  • Figure 6: Nerve Monitoring System Market in Global by End-User (2021-2030)
  • Figure 7: Nerve Monitoring System Market in Global by Geography (2021-2030)
  • Figure 8: Nerve Monitoring System Market in North America (2021-2030)
  • Figure 9: Nerve Monitoring System Market in the US (2021-2030)
  • Figure 10: Nerve Monitoring System Market in Canada (2021-2030)
  • Figure 11: Nerve Monitoring System Market in Mexico (2021-2030)
  • Figure 12: Nerve Monitoring System Market in Europe (2021-2030)
  • Figure 13: Nerve Monitoring System Market in France (2021-2030)
  • Figure 14: Nerve Monitoring System Market in Germany (2021-2030)
  • Figure 15: Nerve Monitoring System Market in the United Kingdom (2021-2030)
  • Figure 16: Nerve Monitoring System Market in Italy (2021-2030)
  • Figure 17: Nerve Monitoring System Market in Spain (2021-2030)
  • Figure 18: Nerve Monitoring System Market in the Rest of Europe (2021-2030)
  • Figure 19: Nerve Monitoring System Market in Asia-Pacific (2021-2030)
  • Figure 20: Nerve Monitoring System Market in China (2021-2030)
  • Figure 21: Nerve Monitoring System Market in Japan (2021-2030)
  • Figure 22: Nerve Monitoring System Market in India (2021-2030)
  • Figure 23: Nerve Monitoring System Market in Australia (2021-2030)
  • Figure 24: Nerve Monitoring System Market in South Korea (2021-2030)
  • Figure 25: Nerve Monitoring System Market in the Rest of Asia-Pacific (2021-2030)
  • Figure 26: Nerve Monitoring System Market in the Rest of the World (2021-2030)
  • Figure 27: Nerve Monitoring System Market in the Middle East (2021-2030)
  • Figure 28: Nerve Monitoring System Market in Africa (2021-2030)
  • Figure 29: Nerve Monitoring System Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Market Opportunities
  • Figure 33: PORTER's Five Force Analysis
目次
Product Code: DIMDCL0024

Nerve Monitoring Systems Market By Product (Nerve Monitors, Nerve Stimulation Electrodes, and Probes), Technology (Electromyography (EMG), Electroencephalography (EEG), Electrocorticography (ECOG), and Evoked Potential (EP)), Application (Neurosurgery, ENT Surgery, Cardiovascular, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to rise in nerve-related disorders and rising use of nerve monitoring systems in trauma cases

The global nerve monitoring systems market was valued at USD 1.28 billion in 2023, growing at a CAGR of 4.17% during the forecast period from 2024 to 2030, to reach USD 1.63 billion by 2030. The demand for nerve monitoring systems is primarily motivated by the rise in nerve-related disorder patient population, easy availability of medical reimbursement for these procedures, increasing demand for advanced products, and the strong presence of device manufacturers in the market.

Nerve Monitoring Systems Market Dynamics:

One of the key factors influencing the growth of the nerve monitoring systems market is the increasing burden of surgical numbers across the globe.

As per the OECD, nearly 9,451 coronary artery bypass graft procedures were performed in the United Kingdom in 2020. Also, approximately 38,859 coronary artery bypass graft procedures were performed in Germany in the same year. The same source stated that 26,355 transluminal coronary angioplasty procedures were performed in Switzerland, in 2020. In the same year, 53,993 transluminal coronary angioplasty procedures were performed in Spain.

Nerve injuries associated with angiography and endovascular interventions are rare and usually transient but may result in significant functional impairment and are largely avoidable. Intercostal nerve damage may occur in three-quarters of all patients undergoing coronary artery bypass graft-internal thoracic artery surgery.

In addition, nearly, 47,083 tonsillectomy procedures were performed in 2019, in Australia. The glossopharyngeal nerve is particularly prone to injury during tonsillectomy because of its position in the tonsillar bed.

The risk of damage to the nerve during any surgical procedure can be reduced if a nerve monitor system is used during the surgery.

Thus, the increasing number of various surgical procedures can increase the risk of nerve damage, leading to an increased demand for nerve monitoring systems, thereby propelling the overall market for nerve monitoring systems in the upcoming years.

However, frequent product recalls and the high cost of the devices may act as a restraint in the growth of the nerve monitoring systems market.

Nerve Monitoring Systems Market Segment Analysis:

Nerve Monitoring Systems by Product (Nerve Monitors, Nerve Stimulation Electrodes and Probes), Technology (Electromyography (EMG), Electroencephalography (EEG), Electrocorticography (ECOG), and Evoked Potential (EP)), Application (Neurosurgery, ENT Surgery, Cardiovascular, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the technology segment of the nerve monitoring systems market, the electromyography (EMG) category is expected to hold the largest share in the nerve monitoring systems market.

EMG is used for the analysis, evaluation, and recording of the electrical activity of skeletal muscles and motor nerve cells associated with them. It assists in the accurate and effective diagnosis of muscle disorders, nerve disorders, and disorders affecting the connection between the muscles and nerves.

Along with this, the EMG can be used to monitor nerve during lumbar decompression surgery, during lumbar interbody fusion surgery from any approach: anterior (ALIF), posterior (PLIF, TLIF), lateral (XLIF®), lumbar total disc replacement procedure, cauda equina surgery, anterior cervical discectomy and fusion (ACDF), cervical total disc replacement, posterior cervical fusion (PCF), spinal cord tumor resections, scoliosis surgery, and thoracic vertebroplasty procedures.

Further, increasing product launches and approvals will also increase the demand for electromyography during the forecast period. For instance, in November 2022, Xavant Technology announced that the FDA has approved the expansion of the sensor technology in its STIMPOD range of Quantitative NMT Monitors to include electromyography (EMG). To date, Xavant's range of Quantitative Neuromuscular Monitoring (NMT) monitors have been equipped with acceleromyography (AMG) sensors only.

Favorable reimbursement policies by the government for EMG-assisted surgical procedures in developed countries and the significant use of EMG nerve monitoring for intraoperative applications will boost the nerve monitoring systems market.

North America is expected to dominate the overall Nerve Monitoring Systems Market:

North America is expected to dominate the overall Nerve Monitoring Systems market during the forecast period. This domination is due to the growing demand for advanced technologies in nerve monitoring systems, and the growing number of surgical procedures, coupled with the presence of major market players in the region.

As per the Lifespan Health System Organization 2022, there are about 5,00,000 open heart surgeries that are performed every year in the United States. Ulnar neuropathy is a documented complication after many operations, but especially after open-heart operations. It is believed that the nerve dysfunction may be due to improper positioning of the forearms and hands during or following the operation. This complication can be avoided if nerve monitoring systems are used while the surgical procedure to monitor the nerve activity and to assess the nerve which is at risk.

The presence of favorable regulatory authority in the country will also increase the overall market as this will result in a higher rate of approval of medical devices. For instance, in October 2020, Medtronic secured Food and Drug Administration (FDA) 510(k) clearance of the NIM Vital nerve monitoring system, which enables doctors to identify, confirm, and monitor nerve function to help cut down the risk of nerve damage during head and neck surgery.

Thus, all the above-mentioned factors will lead to an increase in the United States nerve monitoring systems market growth during the forecasting period of 2024-2030.

Key Nerve Monitoring Systems Market Companies:

Some of the key market companies operating in the Nerve Monitoring Systems market include NuVasive®, Inc., Medtronic PLC, Nihon Kohden Corporation, Natus Medical Incorporated, Innopsys Inc., Neurovision Medical Products, NeuroWave Systems Inc., Cadwell Industries, Inc., Dr. Langer Medical GmbH, Inomed Medizintechnik GmbH, Symmetry Surgical, Checkpoint Surgical Inc., Neurosign®, EMS Handels Gesellschaft mbH, Halyard Health, and others.

Recent Developmental Activities in the Nerve Monitoring Systems Market:

In May 2021, Neurosign announced the US launch of its V4 system for monitoring cranial nerves and spinal nerve roots during surgeries. US Food & Drug Administration (FDA) cleared the V4 4-channel and 8-channel nerve monitoring systems in March.

In October 2020, Medtronic secured FDA 510(k) clearance of the NIM Vital nerve monitoring system, which enables doctors to identify, confirm, and monitor nerve function to help cut down the risk of nerve damage during head and neck surgery.

In February 2019 Alphatec Holdings, Inc. announced that it has received 510(k) clearance from the FDA for its automated SafeOp neuromonitoring system for use in real-time intraoperative nerve location and health assessment.

Key Takeaways from the Nerve Monitoring Systems Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Nerve Monitoring Systems market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the Global Nerve Monitoring Systems Market.

Various opportunities are available for the other competitor in the Nerve Monitoring Systems Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Nerve Monitoring Systems market growth in the coming future?

Target Audience who can be benefited from this Nerve Monitoring Systems Market Report Study

Nerve Monitoring Systems providers

Research organizations and consulting companies

Nerve Monitoring Systems related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Nerve Monitoring Systems

Various end-users want to know more about the Nerve Monitoring Systems Market and the latest technological developments in the Nerve Monitoring Systems market.

Frequently asked questions for Nerve Monitoring Systems Market:

What is a Nerve Monitoring System?

A Nerve Monitoring System is a medical tool used in operations and procedures to check the health and efficiency of nerves. It is mostly used in procedures that put patients at risk for nerve damage, including spinal, thyroid, facial nerve, and several head and neck surgeries.

What is the market for Global Nerve Monitoring System?

The Global Nerve Monitoring System Market was valued at USD 1.28 billion in 2021, growing at a CAGR of 4.71% during the forecast period from 2024 to 2030, to reach USD 1.63 billion by 2030.

Who are the leading companies in the Nerve Monitoring System Market Landscape?

Some of the Key Nerve Monitoring System companies in the Market include Medtronic, Nihon Kohden Corporation, NuVasive, Inc., Natus Medical Incorporated, Inomed Medizintechnik GmbH, NerveVision, Axon Systems, Sentio LLC, Nervomatrix, Nerve Stim SPA, Bovie Medical Corporation, Neurovision Medical Products, Magstim Company Limited, Neurosign Surgical, Checkpoint Surgical, Inc., EMS Handels Gesellschaft mbH, ORIMtec GmbH, Xavant Technology (Pty) Ltd., NeuroWave Systems Inc., Scopis GmbH, and many others.

What are the key strengths of the Nerve Monitoring System Market Report?

Key strengths of Nerve Monitoring System Market Report are 05 Years Forecast, Global Coverage, Competitive Landscape, Market Size, Market Segmentation, Market Company Profiles, Market PORTER's Five Forces Analysis, and Market Share.

Which regions have the highest share in the Nerve Monitoring System Market?

North America is expected to dominate the overall market during the forecast period, 2024 to 2030. This domination is due to the growing demand for advanced technologies in the Nerve Monitoring System. The increased diseases in the region are driving the growth of the Nerve Monitoring System market.

Table of Contents

1. Nerve Monitoring System Market Report Introduction

2. Nerve Monitoring System Market Executive Summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment

3. Regulatory Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Nerve Monitoring System Market Key Factors Analysis

  • 4.1. Nerve Monitoring System Market Drivers
    • 4.1.1. Rise in nerve-related disorder patient population
    • 4.1.2. Easy availability of medical reimbursement for these procedures
    • 4.1.3. Increasing demand for advanced products
  • 4.2. Nerve Monitoring Systems Market Restraints and Challenges
    • 4.2.1. Frequent product recalls
    • 4.2.2. High cost of the devices
  • 4.3. Nerve Monitoring Systems Market Opportunities
    • 4.3.1. Preference for wearable devices
    • 4.3.2. Availability of multimodal monitoring

5. Nerve Monitoring System Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. Nerve Monitoring System Market Layout

  • 6.1. By Product
    • 6.1.1. Nerve Monitors
    • 6.1.2. Nerve Stimulation Electrodes and Probes
  • 6.2. By Technology
    • 6.2.1. Electromyography (EMG)
    • 6.2.2. Electroencephalography (EEG)
    • 6.2.3. Electrocorticography (ECOG)
    • 6.2.4. Evoked Potential (EP)
  • 6.3. By Application
    • 6.3.1. Neurosurgery
    • 6.3.2. ENT Surgery
    • 6.3.3. Cardiovascular
    • 6.3.4. Others
  • 6.4. By End-User
    • 6.4.1. Hospitals
    • 6.4.2. Ambulatory Surgical Centers
    • 6.4.3. Others
  • 6.5 By Geography
    • 6.5.1. North America Nerve Monitoring System Market in USD million (2021-2030)
      • 6.5.1.1. United States Nerve Monitoring System Market in USD million (2021-2030)
      • 6.5.1.2. Canada Nerve Monitoring System Market in USD million (2021-2030)
      • 6.5.1.3. Mexico Nerve Monitoring System Market in USD million (2021-2030)
    • 6.5.2. Europe Nerve Monitoring System Market in USD million (2021-2030)
      • 6.5.2.1. France Nerve Monitoring System Market in USD million (2021-2030)
      • 6.5.2.2. Germany Nerve Monitoring System Market in USD million (2021-2030)
      • 6.5.2.3. United Kingdom Nerve Monitoring System Market in USD million (2021-2030)
      • 6.5.2.4. Italy Nerve Monitoring System Market in USD million (2021-2030)
      • 6.5.2.5. Spain Nerve Monitoring System Market in USD million (2021-2030)
      • 6.5.2.6. Rest of Europe Nerve Monitoring System Market in USD million (2021-2030)
    • 6.5.3. Asia-Pacific Nerve Monitoring System Market in USD million (2021-2030)
      • 6.5.3.1. China Nerve Monitoring System Market in USD million (2021-2030)
      • 6.5.3.2. Japan Nerve Monitoring System Market in USD million (2021-2030)
      • 6.5.3.3. India Nerve Monitoring System Market in USD million (2021-2030)
      • 6.5.3.4. Australia Nerve Monitoring System Market in USD million (2021-2030)
      • 6.5.3.5. South Korea Nerve Monitoring System Market in USD million (2021-2030)
      • 6.5.3.6. Rest of Asia-Pacific Nerve Monitoring System Market in USD million (2021-2030)
    • 6.5.4. Rest of the World (RoW) Nerve Monitoring System Market in USD million (2021-2030)
      • 6.5.4.1. Middle East Nerve Monitoring System Market in USD million (2021-2030)
      • 6.5.4.2. Africa Nerve Monitoring System Market in USD million (2021-2030)
      • 6.5.4.3. South America Nerve Monitoring System Market in USD million (2021-2030)

7. Nerve Monitoring System Company and Product Profiles

  • 7.1. NuVasive®, Inc.
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Nihon Kohden Corporation
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Natus Medical Incorporated
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Innopsys Inc.
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Neurovision Medical Products
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. NeuroWave Systems Inc.
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Cadwell Industries, Inc.
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Dr. Langer Medical GmbH
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Inomed Medizintechnik GmbH
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Medtronic PLC.
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Symmetry Surgical
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Checkpoint Surgical Inc.
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Neurosign®
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. EMS Handels Gesellschaft mbH
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Halyard Health
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us